DH
David Hoang Deutsche Bank Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
17%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
76.2%
Neutral
9.5%
Negative
14.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $103 |
32%
upside
| 1 | +4% |
0
%
| 10 Dec ‘25 29 days ago |
|
|
|
Buy
Maintained
| $45 |
51%
upside
| 3 | -1.3% |
0
%
| 13 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $280 |
6%
downside
| 2 | +88% |
0
%
| 17 Oct ‘25 2 months ago |
|
|
|
Buy
Initiated
| $43 |
42%
upside
| 1 | +92% |
0
%
| 26 Sep ‘25 3 months ago |
|
|
|
Buy
Maintained
| $36 |
4%
downside
| 3 | +2.9% |
0
%
| 25 Sep ‘25 3 months ago |
|
|
|
Sell
Maintained
| $12 |
49%
downside
| 5 | -22% |
0
%
| 15 Aug ‘25 4 months ago |
|
|
|
Buy
Upgraded
| $35 |
31%
upside
| 1 | +23% |
0
%
| 21 May ‘25 7 months ago |
|
|
|
Buy
Initiated
| $67 |
62%
upside
| 1 | +5.1% |
0
%
| 11 Feb ‘25 11 months ago |
|
|
|
Buy
Initiated
| $31 |
80%
upside
| 1 | -18% |
0
%
| 11 Feb ‘25 11 months ago |
|
|
|
Buy
Initiated
| $65 |
482%
upside
| 1 | -71% |
0
%
| 11 Feb ‘25 11 months ago |
|
|
|
Buy
Initiated
| $176 |
5%
upside
| 1 | +33% |
0
%
| 11 Feb ‘25 11 months ago |
|
|
|
Buy
Initiated
| $12 |
44%
downside
| 1 | +136% |
0
%
| 11 Feb ‘25 11 months ago |
|